HOME >> BIOLOGY >> NEWS
UCSF Team Identifies Two Key Molecules In Asthma; Important Finding For New Therapies That Treat Disease At Cell Level

Researchers at the University of California San Francisco have identified two molecules that cause cells to cause asthma--a finding that paves the way for developing more effective drugs for treatment.

The molecules connect with a specific cell receptor to alter cellular structure and set up the mechanism of disease.

"It's like finding the words that connect with the ear that enable the process of hearing to be set in motion. Now we can direct further research into how to manipulate these molecules at the outset to change the outcome of the disease," said David B. Corry, MD, an assistant professor of medicine with the UCSF Lung Biology Center at San Francisco General Hospital Medical Center.

Corry is senior investigator of the study, which is reported in the current issue (December 18) of Science. Scientists nationwide have long focused on trying to understand asthma at the cellular level, and the finding is viewed as a significant breakthrough.

The UCSF researchers conducted the study in a mouse model that mimics human asthma.

The team found that disease begins with the presence in lung tissue of two molecules, interleukin-4 and interleukin-13, which then link up with a certain receptor, named the IL-4 receptor alpha. The molecules are hormone-like substances, called cytokines, produced by CD4+ T cells. The receptor is on the surface of these cells and of cells that make up the lung tissue. CD4 cells are the cells that coordinate the overall action of the human immune system, and cytokines modulate this activity.

It is not known why some people have the two molecules--which are known by the shorthand names of IL-4 and IL-13--in their lungs, but it believed to be linked to a genetic predisposition, Corry said.

"The striking message in the scientific investigation is that all the complexity of asthma as a disease comes down to these three elements: molecule, molecule, receptor," Corry added. The
'"/>

Contact: Corinna Kaarlela
corinna@itsa.ucsf.edu
415-476-3804
University of California - San Francisco
17-Dec-1998


Page: 1 2 3

Related biology news :

1. Idun Pharmaceuticals Identifies Cell Type And Molecular Pathway Involved In TransplantationRelated Liver Damage
2. Leading HIV Researcher Identifies Molecular Mechanism That Enhances NaturalImmune Defense Against HIV Infection
3. Researcher Identifies Two New Violet Species In Central America
4. Team Identifies Switch For Tumor Suppressor Gene
5. Molecules discovered that extend life in yeast, human cells
6. Molecules designed to interfere with DNA upon signal
7. Designer Molecules: Largest Protein Ever Created From Scratch Has Implications For Novel Drug Delivery And Diagnostics
8. NYU And Rockefeller Scientists Design Molecules That Stymie A Notorious Bug
9. Synthetic Lock Binds Some Molecules, Excludes Others
10. NYU Researchers Develop Simple, Predictable And Precise Technique For Arranging DNA Molecules Into Two-Dimensional Crystals
11. Virginia Tech Scientists Study Killer Molecules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
(Date:3/24/2017)... , March 24, 2017 The Controller General of ... Mr. Abdulla Algeen have received the prestigious international IAIR Award ... Continue Reading ... ... and Deputy Controller Abdulla Algeen (small picture on the right) have received ...
Breaking Biology News(10 mins):
(Date:8/16/2017)... ... 2017 , ... Today, 3Bar Biologics Inc ., the ... funding from an impressive group of investors, including Rev1 Ventures, Maumee Ventures, Ohio ... investment, 3Bar is broadening availability of its groundbreaking offering that uses naturally occurring ...
(Date:8/15/2017)... After spending the past two years building a state-of-the-art ... GeneFo now offers this platform to healthcare stakeholders (hospitals, foundations, biopharma ... and data collection vis a vis their members, under their own ... of this offer. ... ...
(Date:8/15/2017)... ... 2017 , ... Any expert in stem cell research or stem cell medicine ... half a century. Despite their essential roles in human health and regenerative medicine, ... tags developed for this purpose also tag other, more abundant, non-stem tissue cells ( ...
(Date:8/15/2017)... ... August 15, 2017 , ... JULABO USA introduces ... the new website makes it easy to navigate through the site whether you’re ... find detailed product information, educational industry content and visit the company’s social media ...
Breaking Biology Technology:
Cached News: